Immunohistochemically proven cytomegalovirus end‐organ disease in solid organ transplant patients: clinical features and usefulness of conventional diagnostic tests
- 19 May 2007
- journal article
- Published by Wiley in Transplant Infectious Disease
- Vol. 9 (3) , 203-210
Abstract
We studied the main clinical features, outcome, and laboratory parameters in a group of solid organ transplant (SOT) patients with immunohistochemically proven cytomegalovirus (CMV) disease. Confirmed CMV cases were obtained through databases. Demographics, clinical data, transplantation type, immunosuppressive regimens, donor and recipient CMV serostatus, therapy, outcome and laboratory results, pp65 antigenemia, and qualitative polymerase chain reaction (PCR) for CMV were analyzed. From 1995 to 2004, 31 cases with complete medical records were identified. Disease appeared between 24 and 2538 days after transplantation but most cases presented in the first 100 days. Gastrointestinal CMV disease was the most frequent form (71%), while thrombocytopenia was present in 50% of cases, and leukopenia was less common (35.5%). CMV pp65 antigenemia was positive in 58% of patients, but its sensitivity increased to 71% if performed during the first 6 months. A qualitative CMV PCR technique gave similar results during this period (71.4%). Most patients were treated with intravenous ganciclovir (n=25; 80.6%). In 4 cases (19.4%), use of foscarnet alone or a sequential regimen with ganciclovir–foscarnet was deemed necessary. Surgical procedures were necessary in 5 patients (16%). The death rate reached 13%. CMV end‐organ disease can be a life‐threatening infection in SOT patients. Gastrointestinal disease was the most frequent end‐organ disease. CMV antigen detection is best suited for the early period after transplantation.Keywords
This publication has 20 references indexed in Scilit:
- Prospective Evaluation of the Clinical Utility of Different Methods for the Detection of Human Cytomegalovirus Disease after Liver TransplantationAmerican Journal of Transplantation, 2004
- Comparison of two quantitative CMV PCR tests, Cobas Amplicor CMV Monitor and TaqMan assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patientsJournal of Clinical Virology, 2004
- CYTOMEGALOVIRUS INFECTION IN ORGAN-TRANSPLANT RECIPIENTS: DIAGNOSTIC VALUE OF PP65 ANTIGEN TEST, QUALITATIVE POLYMERASE CHAIN REACTION (PCR) AND QUANTITATIVE TAQMAN PCRTransplantation, 2004
- Herpes simplex esophagitis from 1307 autopsy casesJournal of Gastroenterology and Hepatology, 2003
- ADENOVIRUS INFECTION IN PEDIATRIC SMALL BOWEL TRANSPLANTATION RECIPIENTSTransplantation, 2003
- Definitions of Cytomegalovirus Infection and Disease in Transplant RecipientsClinical Infectious Diseases, 2002
- Economic impact of cytomegalovirus in solid organ transplantationTransplant Infectious Disease, 2001
- Diagnostic approaches to cytomegalovirus infection in bone marrow and organ transplantationTransplant Infectious Disease, 1999
- Detection of cytomegalovirus in upper gastrointestinal biopsies from heart transplant recipients: comparison of light microscopy, immunocytochemistry, in situ hybridisation, and nested PCR.Journal of Clinical Pathology, 1998
- Association of quantitative cytomegalovirus antigenemia with symptomatic infection in solid organ transplant patientsDiagnostic Microbiology and Infectious Disease, 1996